A5059957498- Cystic Fibrosis Research Advances
- Asthma and respiratory diseases
- Neonatal Respiratory Health Research
- Pediatric health and respiratory diseases
- Tracheal and airway disorders
- Allergic Rhinitis and Sensitization
- COVID-19 Clinical Research Studies
- Cardiac electrophysiology and arrhythmias
- Alcoholism and Thiamine Deficiency
- Sulfur Compounds in Biology
- Pharmacological Receptor Mechanisms and Effects
- Amino Acid Enzymes and Metabolism
- Dysphagia Assessment and Management
- Respiratory and Cough-Related Research
University of Palermo
2022-2024
University of Catania
2013-2018
Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele
2018
University of Belgrade
2013
Bronchiectasis is a chronic respiratory disease characterised by an abnormal dilation of the bronchi associated with clinical syndrome daily productive cough and history frequent exacerbations [1]. Although bronchiectasis awareness has increased over past decades, underestimation this still exists across different settings healthcare professionals [2]. A diagnostic delay seems to exist in bronchiectasis, ranging from 12 17 years, might lead progression worsen patients' outcomes [3, 4, 5]. It...
<b>Introduction:</b> Bronchiectasis (BE) is a chronic disease associated with high morbidity e mortality. Several studies have enlightened pathophysiology, microbiology and epidemiology of the disease, but few known about its phenotypes. We aimed study clinical BE phenotypes in relation to comorbidities (i.e. COPD asthma.) <b>Methods:</b> consecutively enrolled all adult patients CT diagnosis non-cystic fibrosis presenting our Outpatients Clinic 6-months period. Patients traction were...
<b>Background:</b> One of the main severe asthma phenotype is "severe eosinophilic" or "eosinophilic refractory" asthma, for which novel biologic agents are emerging as therapeutical options. In this context, blood eosinophils count one most reliable biomarker. <b>Objective:</b> The aim our study to evaluate performance a point-of-care peripheral counter in clinical setting asthmatics. <b>Methods:</b> Seventy-six patients with were evaluated, cells count, by both and standard analyser....
<b>Introduction:</b> Bronchiectasis (BE) is a complex respiratory disease characterized by recurrent exacerbations. Vit. D plays role in infective enhancing the innate immunity and moderating inflammation. Few studies showed patients affected BE are frequently deficient levels tightly correlate with lung function decline outcomes. Multidimensional scoring systems such as BSI new guidelines have been recently introduced to better understand disease. <b>Aim Objectives:</b> We want correlation...